SubscribeAWIR
- About
- Advocacy
- Overview
- AWIR - Co-Chairs of Advocacy
- AWIR Letter to Insurers, Vendors and Manufacturers Advocating for Provider Relief
- Contact us
- Become an Advocate
- Advocacy 101
- Policy Priorities
- DXA Screening Reimbursement
- To take action on AWIR’s priority legislative issues, please click HERE.
- Step Therapy/Fail First
- Non-Medical Switching
- Prior Authorization
- Workforce Shortage
- Gender Pay Gap
- Accumulator Adjustment Programs
- Fair Drug Pricing & Increased Transparency
- International Pricing Index (IPI) for Part B Drugs
- Take Action
- ArchiveTake
- ArchiveTake2020
- AWIR - Letter of Support OH HB 396
- AWIR - Letter of Support S1128
- AWIR - Comments EEOC-2020-0002
- AWIR DXA Letter - Senate Sponsor Draft
- AWIR - LA HB 263 Support Letter
- AWIR NC - Letter of Support SB632
- AWIR - Written Testimony HB469 (House Health Committee)
- AWIR NC SB 361 - Letter of Support
- MSNJ and AWIR Written Testimony
- ArchiveTake2019
- ArchiveTake2018
- take-archive
- ArchiveTake2020
- Take Action Now!
- Legislator Lookup
- Access AWIR Archived Letters
- ArchiveTake
- Advocacy Resources
- Donate to RheumPAC
- Archived Letters
- Co Chairs
- Education
- Clinical Research
- Meetings
- Contact
- Covid-19
- Addressing Vaccine Hesitancy
- Telehealth is Reimbursed by CMS for Medicare
- COVID-19 Global Rheumatology Alliance — International Case Reporting Registry
- CMS 1135 Waivers to Ease Administrative Burden on Providers for Medicaid Patients
- Global Healthy Living Foundation and Creaky Joints Launch COVID-19 Patient and Family Support Program
- Other Resources
- SignUp- Popup
- Privacy Policy
- Sitemap
- Copyright
- Awir-Portal
- Become a Member
- Sign in
- Quickstart
- EventBrite
- Payment Confirmation
- Sponsors New
- Check Out
- Events Local Filter